The European Medicines Agency has updated its good clinical practice (GCP) guideline to explain how clinical trial sponsors can demonstrate oversight for activities that are delegated to third-party vendors by written contract.
It builds on earlier advice issued by the EMA with respect to general considerations on how contracting should be addressed....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?